Screener
BioSig Technologies, Inc. STEX EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from BioSig Technologies, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: BioSig Technologies, Inc.’s 10-K, filed March 31, 2026. Open the filing →
- Filed
- Mar 31, 2026, 5:30 PM EDT
- Fiscal year
- FY2025
- Accession
- 0001493152-26-014376
FAQ
- What is BioSig Technologies, Inc.'s EBITDA margin?
- BioSig Technologies, Inc. (STEX) reported EBITDA margin of -31,685% in Q4 2024.
- How has BioSig Technologies, Inc.'s EBITDA margin changed year-over-year?
- BioSig Technologies, Inc.'s EBITDA margin increased by 79.7% year-over-year, from -156,394.4% to -31,685%.
- What is the long-term trend for BioSig Technologies, Inc.'s EBITDA margin?
- Over 3 years (2021 to 2024), BioSig Technologies, Inc.'s EBITDA margin has grown at a 61.4% compound annual growth rate (CAGR), from -7,531.3% to -31,685%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about BioSig Technologies, Inc.'s ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude